Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer

NCT05143229 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Alpelisib
DRUG: Sacituzumab govitecan

Sponsor

University of Kansas Medical Center

Collaborators

Novartis Pharmaceuticals
Gilead Sciences